Outsourcing

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

This key bioprocessing segment is expecting continued growth

Fill/Finish Outsourcing

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.

Innovation vs. Capacity:  How CMOs Compete

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

Recipharm Expands Lyophilization Capacity in Italy

Fresenius Kabi will add to its generic, sterile injectable manufacturing at its Melrose Park, Illinois site.

Fresenius Kabi Expands US Sterile Injectables Capacity

Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.

Piramal to Acquire HPAPI CDMO Ash Stevens

CMOs are working hard to improve performance by investigating new technologies for filtration and purification.

Downstream Processing Continues to Worry CMOs

CMOs that offer an innovative service-oriented model will dominate the industry.

What’s Next for  the CMO Industry?

Stability testing programs should provide drug owners the information needed to establish the proper handling, shipping, and shelf-life recommendations for drug products.

Testing Programs Ensure Drug Product Stability and Shelf Life

Bio/pharmaceutical contract service provides continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.

CMOs Invest in Large- and Small-Molecule Manufacturing

The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.

Contract Manufacturing Services